These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 7538080)
1. Primary chemotherapy with bleomycin, ifosfamide and cisplatinum (BIP) followed by radiotherapy in the treatment of advanced cervical cancer. A pilot study. Nevin J; Bloch B; Van Wijk L; Soeters R; Dehaeck K; Ball H; Denny L Eur J Gynaecol Oncol; 1995; 16(1):30-5. PubMed ID: 7538080 [TBL] [Abstract][Full Text] [Related]
2. Experience with bleomycin, ifosfamide, and cisplatin in primary and recurrent cervical cancer. Buxton EJ Semin Oncol; 1992 Apr; 19(2 Suppl 5):9-17; discussion 17-8. PubMed ID: 1384148 [TBL] [Abstract][Full Text] [Related]
3. A randomised, prospective, phase III clinical trial of primary bleomycin, ifosfamide and cisplatin (BIP) chemotherapy followed by radiotherapy versus radiotherapy alone in inoperable cancer of the cervix. Herod J; Burton A; Buxton J; Tobias J; Luesley D; Jordan S; Dunn J; Poole CJ Ann Oncol; 2000 Sep; 11(9):1175-81. PubMed ID: 11061615 [TBL] [Abstract][Full Text] [Related]
4. Chemotherapy followed by radiotherapy versus radiotherapy alone in locally advanced cervical cancer: a randomized study. Kumar L; Kaushal R; Nandy M; Biswal BM; Kumar S; Kriplani A; Singh R; Rath GK; Kochupillai V Gynecol Oncol; 1994 Sep; 54(3):307-15. PubMed ID: 7522200 [TBL] [Abstract][Full Text] [Related]
5. Bleomycin, cisplatinum and ifosfamide infusion chemotherapy in advanced/recurrent cancer of cervix. Singhal RM; Jindel R; Gupta AK Indian J Cancer; 1993 Dec; 30(4):158-63. PubMed ID: 7515843 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of paclitaxel, ifosfamide, and cisplatin as a neoadjuvant chemotherapy in locally advanced cervical carcinoma. Scandurra G; Scibilia G; Banna GL; D'Agate G; Lipari H; Gieri S; Scollo P J Gynecol Oncol; 2015 Apr; 26(2):118-24. PubMed ID: 25686397 [TBL] [Abstract][Full Text] [Related]
7. Single agent versus combination chemotherapy in recurrent cervical cancer. Kumar L; Pokharel YH; Kumar S; Singh R; Rath GK; Kochupillai V J Obstet Gynaecol Res; 1998 Dec; 24(6):401-9. PubMed ID: 10063235 [TBL] [Abstract][Full Text] [Related]
9. Bleomycin-ifosfamide-cis-platinum (BIP) in pelvic recurrence of previously irradiated cervical carcinoma: a second look. Ramm K; Vergote IB; Kaern J; Tropé CG Gynecol Oncol; 1992 Aug; 46(2):203-7. PubMed ID: 1379961 [TBL] [Abstract][Full Text] [Related]
10. The role of ifosfamide in cervical cancer. Buxton EJ; Blackledge G; Mould JJ; Monaghan J; Paterson M; Tobias J; Alcock C; Spooner D; Meanwell CA Semin Oncol; 1989 Feb; 16(1 Suppl 3):60-7. PubMed ID: 2468183 [TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant bleomycin, ifosfamide and cisplatin in cervical cancer. Tobias J; Buxton EJ; Blackledge G; Mould JJ; Monaghan J; Spooner D; Chetiyawardana A Cancer Chemother Pharmacol; 1990; 26 Suppl():S59-62. PubMed ID: 1693316 [TBL] [Abstract][Full Text] [Related]
12. Retrospective analysis of concurrent chemoradiation with the combination of bleomycin, ifosfamide and cisplatin (BIP) for uterine cervical cancer. Aoki M; Akahira J; Niikura H; Saito S; Abe Y; Aida T; Sato N; Kitamura T; Otsuki K; Katahira A; Utsunomiya H; Okamura C; Takano T; Ito K; Okamura K; Yaegashi N Tohoku J Exp Med; 2004 Dec; 204(4):309-15. PubMed ID: 15572856 [TBL] [Abstract][Full Text] [Related]
13. Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed by consolidation chemotherapy for women with locally advanced carcinoma of the uterine cervix--final results of a prospective phase II-study. Vrdoljak E; Omrcen T; Novaković ZS; Jelavić TB; Prskalo T; Hrepić D; Hamm W Gynecol Oncol; 2006 Nov; 103(2):494-9. PubMed ID: 16814371 [TBL] [Abstract][Full Text] [Related]
14. Ifosfamide and cisplatin as neoadjuvant chemotherapy for advanced cervical carcinoma. Leone B; Vallejo C; Perez J; Cuevas MA; Machiavelli M; Lacava J; Focaccia G; Ferreyra R; Suttora G; Romero A; Castaldi J; Arroyo A; Rabinovich M Am J Clin Oncol; 1996 Apr; 19(2):132-5. PubMed ID: 8610635 [TBL] [Abstract][Full Text] [Related]
15. The addition of bleomycin and dose-escalated ifosfamide to the combination of cisplatin plus ifosfamide does not improve survival in advanced or recurrent cervical carcinoma. Hempling RE; Eltabbakh GH; Piver MS; Recio FO; O'Neill CP Am J Clin Oncol; 1997 Jun; 20(3):315-8. PubMed ID: 9167762 [TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant chemotherapy in locally advanced cervical cancer: two randomised studies. Kumar L; Grover R; Pokharel YH; Chander S; Kumar S; Singh R; Rath GK; Kochupillai V Aust N Z J Med; 1998 Jun; 28(3):387-90. PubMed ID: 9673754 [TBL] [Abstract][Full Text] [Related]
17. [Concurrent chemoradiotherapy versus radiotherapy in advanced cervical carcinoma]. Zeng SY; Li LY; Shu KY; Pan M; Li HP; Luo B Ai Zheng; 2008 Sep; 27(9):942-6. PubMed ID: 18799032 [TBL] [Abstract][Full Text] [Related]
18. A randomized study of primary bleomycin, vincristine, mitomycin and cisplatin (BOMP) chemotherapy followed by radiotherapy versus radiotherapy alone in stage IIIB and IVA squamous cell carcinoma of the cervix. Tabata T; Takeshima N; Nishida H; Hirai Y; Hasumi K Anticancer Res; 2003; 23(3C):2885-90. PubMed ID: 12926129 [TBL] [Abstract][Full Text] [Related]
19. Clinical Outcome of Neoadjuvant Radiochemotherapy in Locally Advanced Cervical Cancer: Results of an Open Prospective, Multicenter Phase 2 Study of the North-Eastern German Society of Gynecological Oncology. Koensgen D; Sehouli J; Belau A; Weiss M; Stope MB; Grokopf V; Eichbaum M; Ledwon P; Lichtenegger W; Zygmunt M; Köhler G; Mustea A Int J Gynecol Cancer; 2017 Mar; 27(3):500-506. PubMed ID: 28187089 [TBL] [Abstract][Full Text] [Related]
20. Bleomycin, ifosfamide, and cisplatin (BIP) in patients with recurrent and advanced cervical cancer. Manetta A Gynecol Oncol; 1991 Jul; 42(1):104-5. PubMed ID: 1717353 [No Abstract] [Full Text] [Related] [Next] [New Search]